Pediatrix Medical Group Inc reports results for the quarter ended June 30 - Earnings Summary
05/08/2025 14:31
Pediatrix Medical Group Inc MD.N reported quarterly adjusted earnings of 53 cents per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 34 cents. The mean expectation of eight analysts for the quarter was for earnings of 42 cents per share. Wall Street expected results to range from 40 cents to 45 cents per share. Revenue fell 7% to $468.84 million from a year ago; analysts expected $464.32 million. Pediatrix Medical Group Inc's reported EPS for the quarter was 46 cents. The company reported quarterly net income of $39.26 million. Pediatrix Medical Group Inc shares had fallen by 14.3% this quarter and lost 6.2% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had risen by about 0.8% in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy" Wall Street's median 12-month price target for Pediatrix Medical Group Inc is $16.00, about 23.1% above its last closing price of $12.30 This summary was machine generated from LSEG data August 5 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Jun. 30 2025 | 0.42 | 0.53 | Beat |
| Mar. 31 2025 | 0.24 | 0.33 | Beat |
| Dec. 31 2024 | 0.37 | 0.51 | Beat |
| Sep. 30 2024 | 0.37 | 0.44 | Beat |